Status of essential trace elements in untreated carcinomas of the head and neck;Status essenzieller spurenelemente bei unbehandelten Kopf-Hals-karzinomen

Laryngo- Rhino- Otologie

Volumn 82, Issue 8, 2003, Pages 573-577

  Büntzel, Jens ^a   Glatzel, M ^b   Micke, O ^c   Frohlich D ^b  

^a Sudharz Krankenhaus Nordhausen   (Germany)

^b Strahlenklinik Zentralklinikum Suhl gGmbH ^*  (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Head and neck cancer; Redox status; Trace elements

Indexed keywords

COPPER; GLUTATHIONE PEROXIDASE; IRON; MALONALDEHYDE; SELENIUM; TRACE ELEMENT; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL BLOOD LEVEL; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERUM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; COPPER; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; IRON; MALE; MALONDIALDEHYDE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; REFERENCE VALUES; SELENIUM; TRACE ELEMENTS; ZINC;

EID: 18744426742     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41233     Document Type: Article

References (20)

1. Schüller P, Püttmann S, Mücke R, Senner V, Schäfer U, Kisters K, Micke O. From the radiolysis of water to the role of trace elements in radiobiology and clinical radiation therapy: following a logical chain. Trace Elem Electrolytes 2001; 18: 186-192
2. Schrauzer GN. Selen: Neue Entwicklungen aus Biologie, Biochemie und Medizin 3. Auflage Heidelberg, Leipzig: Johann Ambrosius Barth, 1998
3. Rostkowa-Nadolska B, Pospiech L, Bochnia M. Content of trace elements in serum of patients with carcinoma of the larynx. Arch Immunol Ther Exp (Warsz) 1999; 47: 321-325
4. Westin T, Ahlbom E, Johansson K, Sandstrom B, Karlberg I, Edstrom S. Circulating levels of selenium and zinc in relation to nutrition status in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1989; 115: 1079-1082
5. De Jorge FB, Paiva LJ. Chemistry of copper, magnesium and sulfur in malignant of the head (mouth, nose, face and ear). Rev Bras Med 1967; 24: 416-420
6. Silverman S Jr, Thompson JS. Serum zinc and copper in oral/oropharyngeal carcinoma. A study of seventy-five patients. Oral Surg Oral Med Oral Pathol 1984; 57: 34-36
7. Mücke R, Jaekel R. Erythrozyten- und Vollblutsuperoxiddismutase sowie Plasma-Malondialdehyd bei und nach venösen Thrombosen und chronisch-myeloproliferativen Erkrankungen. Inauguraldissertation an der Medizinischen Fakultät der Universität Rostock 1999: 6-8
8. Rote Liste 2002. Editio Cantor Aulendorf 2002
9. Mathur A, Wallenius K, Abdulla M. Influence of zinc on onset and progression of oral carcinogenesis in rats. Acta Odontol Scand 1979; 37: 277-284
10. Jayadeep A, Raveendran Pillai K, Kannan S, Nalinakumari KR, Mathew B, Krishnan Nair M, Menon VP. Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma. J Exp Clin Cancer Res 1997; 16: 295-300
11. Tomasits J, Dostal V, Kirschner H, Dostal E, Glöckner W. Plasmaproteindiagnostik, Immunparameter und Tumormarker. In: H. Wrba (ed). Kombinierte Tumortherapie. Grundlagen, Möglichkeiten und Grenzen adjuvanter Methoden. 2. Aufl. Stuttgart: Hippokrates, 1995: 40-58
12. Büntzel J, Lochner P, Glatzel M, Küttner K. Cancer-related and therapy-induced anemia in head and neck cancer - incidence, treatment and prognostic impact. In: Alvarez Vincent JJ (ed). 1st World Congress on Head and Neck Oncology. Bologna: Monduzzi, 1998: 1285-1290
13. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-241
14. Mücke R, Büntzel J, Schönekaes K, Glatzel M, Kisters K, Bruns F, Micke O. Selen in der Onkologie - Möglichkeiten und Grenzen. Im Focus Onkologie 2/2002; 5: 77-80
15. Bayer W, Schmidt KH. Spurenelemente in der Onkologie. In: Wrba H (ed). Kombinierte Tumortherapie. Grundlagen, Möglichkeiten und Grenzen adjuvanter Methoden. 2. Aufl. Stuttgart: Hippokrates, 1995: 318-323
16. Mücke R, Micke O, Schönekaes KG. Serum selenium levels, glutathione peroxidase activities and serum redox potential levels in patients with untreated non-small cell lung cancer and adenocarcinoma of the rectum. Trace Elem Electrolytes 2000; 17: 119-123
17. Schrauzer GN. Anticarcinogenic effects of selenium. Cell Mol Life Sci 2002; 57: 1864-1873
18. Seidman MD, Quirk WS, Shirwany NA. Reactive oxygen metabolites, antioxidants and head and neck cancer. Head Neck 1999; 21: 467-479
19. Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: The use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 1990; 18: 1069-1075
20. Strnad V, Sauer R. Radioprotection of head and neck tissue by amifostine. In: Dörr W, Engenhart-Cabillic R, Zimmermann JS (eds). Normal tissue reactions in radiotherapy and oncology. Front Radiat Ther Oncol Basel: Karger, 2002; 37: 101-111